MS Speaks

Multiple Sclerosis => TREATMENTS => TYSABRI (natalizumab) => Topic started by: agate on August 22, 2018, 02:32:46 pm

Title: Abreos Biosciences launches lab test for precision dose monitoring of Tysabri
Post by: agate on August 22, 2018, 02:32:46 pm

Abreos Biosciences has come out with a test for monitoring the levels of Tysabri in patients' systems for the purpose of getting a closer control of the PML risk:

https://www.prweb.com/releases/abreos_biosciences_launches_laboratory_developed_test_for_precision_dose_monitoring_of_natalizumab_tysabri/prweb15705476.htm